Skip to content

Clinical trials

Completed Phase 2/3 Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 2/3 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20052
20061
20071
20083
20091
20101
20111
20131

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Aging (NIA)3
UMC Utrecht2
Anesiva, Inc.1
Brigham and Women's Hospital1
Chugai Pharma USA1
Dr. Grant Pierce1
Isfahan University of Medical Sciences1
Medtronic Endovascular1
Merck Sharp & Dohme LLC1
Oregon State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis18
Cardiovascular Diseases5
Coronary Artery Disease4
Peripheral Vascular Diseases3
Diabetes Mellitus2
Graft Occlusion, Vascular2
Inflammation2
Insulin Resistance2
Peripheral Arterial Disease2
Angina, Stable1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.